4.7 Article

Characteristics of Undertreatment in COPD in the General Population

期刊

CHEST
卷 144, 期 6, 页码 1811-1818

出版社

ELSEVIER
DOI: 10.1378/chest.13-0453

关键词

-

资金

  1. GlaxoSmithKline [EPI 115882-EUPharmaLocal]
  2. Capital Region of Copenhagen
  3. Danish Heart Foundation
  4. Danish Lung Foundation
  5. Velux Foundation
  6. Herlev University Hospital

向作者/读者索取更多资源

Background: We wished to characterize undertreatment in COPD. Methods: Among 5,812 individuals with COPD defined by FEV1/FVC, 0.7 participating in the Copenhagen General Population Study, we identified 920 individuals with FEV1, 60% predicted. Prescriptions were identified in an all-inclusive nationwide registry. For each individual, we examined treatment with medication in the year before the day of the baseline examination, as well as treatment in the first year after the examination. Multivariable logistic regression analyses were applied in individuals with FEV1, 60% predicted to identify predictors of treatment in the first year after baseline. Results: Only 30% of individuals with COPD and FEV1, 60% predicted were treated with medication in the year before the examination, whereas 42.2% were treated with medication in the first year after. Reporting six to 10 previous respiratory infections during the preceding 10 years that required consulting a doctor and/or staying home from work was the strongest predictor of treatment with medication (OR, 7.9; 95% CI, 3.5-19.8; P<.001). Breathlessness, low FEV1, previous admissions with a discharge diagnosis of COPD, and former smoking were also predictors of treatment with medication, whereas comorbidity predicted lack of treatment. In subgroup analysis, among individuals with FEV1 <50% predicted, visits to the general practitioner and age were additional predictors of treatment, whereas male sex and being a widow/widower predicted lack of treatment. Conclusions: In this study, we observed important characteristics of a major undertreatment in individuals with COPD in the general population. Previous reported respiratory infections were the strongest predictors of treatment with medications, which indicates that most COPD treatment is initiated because of acute exacerbations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据